Quality Outlook Blog: Why Indirect Benefits of Cancer Care Matter

May 2020

In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways, Partner Tom Valuck and Directors David Blaisdell and Manasi Tirodkar explore how indirect benefits related to the use of cancer care products and services fit into health care value assessments. These indirect benefits include avoidance of costs to patients, caregivers, employers, and society more broadly. In addition, the Discern authors recommend action steps to evaluate and measure the indirect benefits of cancer care to improve coverage and payment in the value-based environment.

“Beyond Face Value: Why Indirect Benefits of Cancer Care Matter” is Discern’s fifth blog post in the Quality Outlook series. The series explores key issues in oncology quality and value through articles focused on measurement, value-based payment, and quality improvement.

Read the Indirect Benefits blog post here. Read other Quality Outlook posts here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO